WC-Co nanoparticles in initiating angiogenesis by reactive oxygen species

WC-Co纳米颗粒通过活性氧引发血管生成

基本信息

  • 批准号:
    7851049
  • 负责人:
  • 金额:
    $ 40.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-01 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Nanoparticles are engineered structures with dimension of 100 nanometers or smaller. Available evidence indicates that the properties of nanoparticles may substantially differ from the same composition in the micrometer scale. However, the biological effects of nanoparticle exposure are little known yet. Our preliminary results show that exposure of epithelial cells to tungsten carbide cobalt (WC-Co) nanoparticles produced high levels of reactive oxygen species (ROS). WC-Co nanoparticles induced AKT and ERK1/2 activation, and increased the transcriptional activation of AP-1, NF-kappaB, and VEGF. We hypothesize that WC-Co nanoparticles induce angiogenesis through ROS signaling, which in turn regulates PI3K, AKT and ERK1/2 activities. To test this hypothesis, we will perform the following four aims. In Aim 1, we will identify which species of ROS are induced in lung epithelial cells exposed to the nanoparticls and the mechanism of ROS generation in the cells. Aim 2 will determine what signaling pathways and molecules are regulated by the nanoparticles, and whether they are mediated through ROS in the cells. Aim 3 will determine the effects of the nanoparticles in lung epithelial cells for inducing angiogenesis, and roles of ROS and signaling molecules in nanoparticle-inducing angiogenesis. Aim 4 will use mouse model and transgenic mice to further study the roles and mechanism of WC-Co nanoparticles in regulating signaling pathways and angiogenesis. This proposed work will provide the roles and mechanism of the nanoparticles in angiogenesis and other biological effects, and identify specific ROS-mediated signaling molecules for regulating angiogenesis. After we learn the biological responses of the nanoparticles and the underlined mechanism, we will be able to develop mechanism-based interventions, such as specific antioxidants, to decrease toxicity of WC-Co nanoparticles and other nanoparticles in the future. Nanoparticles are engineered structures with dimension of 100 nanometers or smaller. However, the biological effects of nanoparticle exposure are little known yet. In this study, we plan to study the biological effects of WC-Co nanoparticles by determining the roles and mechanism of the nanoparticles in inducing ROS production, PI3K, AKT, and ERK activation in human lung epithelial cells, and to study the effects of the nanoparticles in inducing angiogenesis. This proposed work will provide the roles and mechanism of the nanoparticles in inducing angiogenesis and other biological effects. This information is also useful for us to develop mechanism-based interventions, such as specific antioxidants, to decrease toxicity of WC-Co nanoparticles and other nanoparticles in the future.
描述(申请人提供):纳米颗粒是尺寸在100纳米或更小的工程结构。现有证据表明,纳米颗粒的性质可能与微米级的相同成分有很大不同。然而,纳米颗粒暴露的生物学效应还鲜为人知。我们的初步结果表明,上皮细胞暴露在碳化钨钴纳米颗粒(WC-Co)中会产生高水平的活性氧(ROS)。WC-Co纳米颗粒可诱导AKT和ERK1/2的激活,并增强AP-1、NF-kappaB和VEGF的转录激活。我们推测WC-Co纳米颗粒通过ROS信号通路诱导血管生成,进而调节PI3K、AKT和ERK1/2的活性。为了验证这一假设,我们将实现以下四个目标。在目标1中,我们将确定暴露于纳米颗粒的肺上皮细胞中哪些种类的ROS被诱导,以及细胞中ROS的产生机制。目标2将确定纳米颗粒调节哪些信号通路和分子,以及它们是否通过细胞内的ROS介导。目的3将确定纳米颗粒在肺上皮细胞中诱导血管生成的作用,以及ROS和信号分子在纳米颗粒诱导血管生成中的作用。目的利用小鼠模型和转基因小鼠,进一步研究WC-Co纳米颗粒在调节信号通路和血管生成中的作用和机制。这项拟议的工作将提供纳米颗粒在血管生成和其他生物学效应中的作用和机制,并识别特定的ROS介导的信号分子来调节血管生成。在我们了解了纳米颗粒的生物反应和所强调的机制后,我们将能够开发基于机理的干预措施,例如特定的抗氧化剂,以降低WC-Co纳米颗粒和其他纳米颗粒的毒性。纳米粒子是尺寸为100纳米或更小的工程结构。然而,纳米颗粒暴露的生物学效应还鲜为人知。本研究拟通过研究WC-Co纳米颗粒在诱导人肺上皮细胞ROS生成、PI3K、AKT和ERK活化中的作用和机制,研究WC-Co纳米颗粒的生物学效应,并研究其诱导血管生成的作用。这项拟议的工作将提供纳米颗粒在诱导血管生成和其他生物效应方面的作用和机制。这些信息也有助于我们开发基于机制的干预措施,如特定的抗氧化剂,以降低未来WC-Co纳米颗粒和其他纳米颗粒的毒性。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
PI3K/PTEN signaling in angiogenesis and tumorigenesis.
  • DOI:
    10.1016/s0065-230x(09)02002-8
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Jiang, Bing-Hua;Liu, Ling-Zhi
  • 通讯作者:
    Liu, Ling-Zhi
Roles of EGFR, PI3K, AKT, and mTOR in heavy metal-induced cancer.
  • DOI:
    10.2174/1568009611313030004
  • 发表时间:
    2013-02
  • 期刊:
  • 影响因子:
    3
  • 作者:
    R. Carpenter;B. Jiang
  • 通讯作者:
    R. Carpenter;B. Jiang
Role and mechanism of arsenic in regulating angiogenesis.
  • DOI:
    10.1371/journal.pone.0020858
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Liu LZ;Jiang Y;Carpenter RL;Jing Y;Peiper SC;Jiang BH
  • 通讯作者:
    Jiang BH
Nanomedicine as an emerging approach against intracellular pathogens.
纳米医学作为针对细胞内病原体的新兴方法。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BingHua Jiang其他文献

BingHua Jiang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BingHua Jiang', 18)}}的其他基金

Chromium in carcinogenesis and angiogenesis
铬在致癌和血管生成中的作用
  • 批准号:
    10328704
  • 财政年份:
    2018
  • 资助金额:
    $ 40.74万
  • 项目类别:
Mechanism of lung cancer resistance to tyrosine kinase inhibitor and radiation treatments
肺癌对酪氨酸激酶抑制剂和放射治疗的耐药机制
  • 批准号:
    10303868
  • 财政年份:
    2018
  • 资助金额:
    $ 40.74万
  • 项目类别:
Chromium in carcinogenesis and angiogenesis
铬在致癌和血管生成中的作用
  • 批准号:
    9980376
  • 财政年份:
    2018
  • 资助金额:
    $ 40.74万
  • 项目类别:
NOX4 mediates oxidative stress in ovarian tumor growth and treatment response
NOX4 介导卵巢肿瘤生长和治疗反应中的氧化应激
  • 批准号:
    9187916
  • 财政年份:
    2015
  • 资助金额:
    $ 40.74万
  • 项目类别:
Reactive Oxygen Species-Induced CXCL8 in Ovarian Cancer
活性氧诱导的 CXCL8 在卵巢癌中的作用
  • 批准号:
    8919299
  • 财政年份:
    2014
  • 资助金额:
    $ 40.74万
  • 项目类别:
Reactive Oxygen Species-Induced CXCL8 in Ovarian Cancer
活性氧诱导的 CXCL8 在卵巢癌中的作用
  • 批准号:
    8692266
  • 财政年份:
    2014
  • 资助金额:
    $ 40.74万
  • 项目类别:
Molecular Mechanism of Arsenic Carcinogenesis
砷致癌的分子机制
  • 批准号:
    8632516
  • 财政年份:
    2013
  • 资助金额:
    $ 40.74万
  • 项目类别:
Molecular Mechanism of Arsenic Carcinogenesis
砷致癌的分子机制
  • 批准号:
    9301706
  • 财政年份:
    2013
  • 资助金额:
    $ 40.74万
  • 项目类别:
Molecular Mechanism of Arsenic Carcinogenesis
砷致癌的分子机制
  • 批准号:
    9185317
  • 财政年份:
    2013
  • 资助金额:
    $ 40.74万
  • 项目类别:
WC-Co nanoparticles in initiating angiogenesis by reactive oxygen species
WC-Co纳米颗粒通过活性氧引发血管生成
  • 批准号:
    7362918
  • 财政年份:
    2009
  • 资助金额:
    $ 40.74万
  • 项目类别:

相似海外基金

Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
  • 批准号:
    24K18002
  • 财政年份:
    2024
  • 资助金额:
    $ 40.74万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
  • 批准号:
    2222215
  • 财政年份:
    2023
  • 资助金额:
    $ 40.74万
  • 项目类别:
    Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
  • 批准号:
    23K09272
  • 财政年份:
    2023
  • 资助金额:
    $ 40.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
  • 批准号:
    10652764
  • 财政年份:
    2023
  • 资助金额:
    $ 40.74万
  • 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
  • 批准号:
    10730652
  • 财政年份:
    2023
  • 资助金额:
    $ 40.74万
  • 项目类别:
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
  • 批准号:
    22K11609
  • 财政年份:
    2022
  • 资助金额:
    $ 40.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
  • 批准号:
    22K16720
  • 财政年份:
    2022
  • 资助金额:
    $ 40.74万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
  • 批准号:
    RGPIN-2018-04107
  • 财政年份:
    2022
  • 资助金额:
    $ 40.74万
  • 项目类别:
    Discovery Grants Program - Individual
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
  • 批准号:
    RGPIN-2019-05674
  • 财政年份:
    2022
  • 资助金额:
    $ 40.74万
  • 项目类别:
    Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
  • 批准号:
    22K12824
  • 财政年份:
    2022
  • 资助金额:
    $ 40.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了